Exclusive License Agreement Between The Research Foundation for The State University of New York and Quadrant Biosciences Inc. (COVID-19 Saliva Diagnostic)Exclusive License Agreement • April 29th, 2021 • Quadrant Biosciences Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (hereinafter, “Agreement”) is made and is effective as of the date of the last signature below (hereinafter, “Effective Date”) by and between The Research Foundation for The State University of New York (“SUNY”), on behalf of Upstate Medical University (“Upstate”), a non-profit educational corporation, organized and existing under the laws of the State of New York, having offices at 750 East Adams St., WH 1109C, Syracuse, NY 13210 (hereinafter, “Foundation” or “Licensor”) and Quadrant Biosciences Inc., a Delaware corporation, having a primary address at 505 Irving Ave., Suite 3100AB, Syracuse, NY 13210 (hereinafter, “Licensee”, and together with Foundation, the “Parties”, and each individually a “Party”).
